ILMN|Earnings Snapshot
EPS
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q1'26 | $1.06 | - | - |
| Q2'26 | $1.23 | $1.31 | +6.8% |
| Q1'25 | $0.94 | $0.97 | +3.3% |
Revenue
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q1'26 | $1.1B | - | - |
| Q2'26 | $1.2B | $1.2B | +0.6% |
| Q1'25 | - | $1.0B | - |
ILMN|Monthly Returns
Market Data
ILMN Stock Snapshot
- Market cap
- 36.18B
- P/E ratio
- 43.9
- Day range
- $239.46 – $248.30
- News sentiment
- 69/100 · Bullish
- Analyst target
- $202.65 (-15.8%)
- Consensus
- Buy · 28 analysts
Momentum is working in ILMN's favour - the indicator set leans bullish rather than mixed. In Healthcare, names this size usually take direction from sector flows before company-level news.
Behaviour On Record
What ILMN's own history says about today's numbers
- Realized volatility (21d)
- 52.6% 83rd pct
- Below its peak
- -52.2%
- vs 200-day average
- +56.2%
- Up days (1y)
- 52%
Illumina, Inc. is currently running 52.6% annualised volatility over the last 21 sessions. Measured against ILMN's own 13 years of daily returns rather than a market-wide average, that is the 83rd percentile — elevated for this stock, against a typical reading of 36.4%. The distinction matters because a number that looks calm for one stock is turbulent for another, and the absolute figure on its own tells you neither.
ILMN is trading -52.2% below its running peak. Across 12 full years on file, its median worst-drawdown-in-a-year was -34.3%, and the deepest was -60.1% in 2023. The current drawdown is already deeper than this stock's typical annual low point, which puts it in the part of its range where past recoveries began — and where past declines also continued.
Price sits +56.2% from its 200-day moving average. Against every other day in its history, that gap ranks at the 100th percentile — a wider gap than this stock usually carries. Over the past year ILMN closed higher on 52% of sessions, and it is currently 1 session into a rising streak.
On September specifically: over 13 years of records, ILMN finished the month higher 5 of 13 times, with a median return of -3.8% and an average of -2.2%. Its strongest month historically has been January at +4.5% on average, its weakest February at -3.4%. Seasonality is a weak signal on its own — a decade is a small sample and regimes change — but it is a real distribution rather than a rule of thumb.
Overnight risk is measurable too: ILMN has opened more than 2% away from the prior close in 172 of 3,267 sessions (5.3% of the time), with the largest gaps running +8.1% and -10.2%. For anyone holding through an event, that rate is a better guide to overnight exposure than the intraday range.
All figures computed from 3,268 daily closes between 2013-09-23 and 2026-09-21, split-adjusted, recomputed daily. Percentiles are against ILMN's own 13-year history, not a peer group or index.
Sector Rotation
Is money rotating into or out of ILMN's sector?
Illumina, Inc. sits in the Health Care sector, currently ranked 5th of 11 GICS sectors by relative-strength rotation score (improving).
- Sector rank
- #5 of 11
- Sector state
- Improving
- Sector rotation score
- 80
Analyst Rating Changes
Are analysts turning bullish or bearish on ILMN?
UBS most recently upgraded Illumina, Inc. to Buy on Sep 9, 2026 with a price target of $260 (from $135). Over the last 90 days, coverage has run 1 upgrade against 0 downgrades, a net bullish lean.
- Latest action
- UBS — Buy
- 90-day upgrades
- 1
- 90-day downgrades
- 0
- Net rating momentum
- +1